More than 90 patient advocates, including representatives of 20 organizations, are urging the National Institutes of Health to take “immediate action” to ensure better reporting of results from human testing of new treatments.
The advocates recently called on the agency to correct its “failure to demand accountability” from institutions that flout a federal law requiring public posting of outcomes of many clinical trials.
“Patient advocacy groups across the US are very concerned with the disregard for human life, patient safety, transparency, and accountability the NIH, and the FDA, have shown by not enforcing timely reporting of” clinical trial results, the advocates wrote in a January letter to NIH director Dr. Francis Collins.
